Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Strobel

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 18, 2025
Ethics and trustworthiness of artificial intelligence in Hepato-Pancreato-Biliary surgery: a snapshot of insights from the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) surveyNiki Rashidian, Mohammed Abu Hilal, Isabella Frigerio, et al.
Cancer Letters|April 14, 2025
Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disordersCristiano Ramos, Natalie Walterskirchen, Viktoria Knöbl, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2025
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic studyUjjwal M Mahajan, Bettina Oehrle, Elisabetta Goni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2017
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA ConsortiumDaniele Campa, Ofure Obazee, Manuela Pastore, et al.
Annals of Surgery|April 29, 2021
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic SurgeryFabian Schuh, André L Mihaljevic, Pascal Probst, et al.
Scientific Reports|December 24, 2016
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsDaniele Campa, Gabriele Capurso, Manuela Pastore, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 18, 2025
Ethics and trustworthiness of artificial intelligence in Hepato-Pancreato-Biliary surgery: a snapshot of insights from the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) surveyNiki Rashidian, Mohammed Abu Hilal, Isabella Frigerio, et al.
Cancer Letters|April 14, 2025
Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disordersCristiano Ramos, Natalie Walterskirchen, Viktoria Knöbl, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2025
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic studyUjjwal M Mahajan, Bettina Oehrle, Elisabetta Goni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2017
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA ConsortiumDaniele Campa, Ofure Obazee, Manuela Pastore, et al.
Annals of Surgery|April 29, 2021
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic SurgeryFabian Schuh, André L Mihaljevic, Pascal Probst, et al.
Scientific Reports|December 24, 2016
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsDaniele Campa, Gabriele Capurso, Manuela Pastore, et al.
Pageof 24